NKGEN BIOTECH INC(NKGN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

NKGN NKGEN BIOTECH INC

Closed 05-13 16:00:00 EDT

1.24

-0.02

-1.59%

盘后1.24

+0.000.00%

19:17 EDT

High1.28	Low1.22	Vol62.31K
Open1.23	D1 Closing1.26	Amplitude4.86%
Mkt Cap28.28M	Tradable Cap9.98M	Total Shares22.81M
T/O77.80K	T/O Rate0.77%	Tradable Shares8.05M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"NKGN","market":"US","secType":"STK","nameCN":"NKGEN BIOTECH INC","latestPrice":1.24,"timestamp":1715630400000,"preClose":1.26,"halted":0,"volume":62306,"hourTrading":{"tag":"盘后","latestPrice":1.24,"preClose":1.24,"latestTime":"19:17 EDT","volume":1107,"amount":1372.4298,"timestamp":1715642236024},"delay":0,"floatShares":8047094,"shares":22805643,"eps":-5.377227,"marketStatus":"Closed","change":-0.02,"latestTime":"05-13 16:00:00 EDT","open":1.23,"high":1.2812,"low":1.22,"amount":77801.54581420001,"amplitude":0.048571,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.377227,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1715673600000},"marketStatusCode":5,"adr":0,"exchange":"NYSE","adjPreClose":1.26,"preHourTrading":{"tag":"盘前","latestPrice":1.25,"preClose":1.26,"latestTime":"09:29 EDT","volume":673,"amount":865.4030951000001,"timestamp":1715606993023},"postHourTrading":{"tag":"盘后","latestPrice":1.24,"preClose":1.24,"latestTime":"19:17 EDT","volume":1107,"amount":1372.4298,"timestamp":1715642236024},"volumeRatio":0.604239},"requestUrl":"/m/hq/s/NKGN","defaultTab":"news","newsList":[{"id":"2431734289","title":"NKTR, IMNM and MAIA are among premarket gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2431734289","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2431734289?lang=en_us&edition=fundamental","pubTime":"2024-04-30 20:42","pubTimestamp":1714480935,"startTime":"0","endTime":"0","summary":"Gainers: Cyclacel Pharmaceuticals Inc (CYCC) +60% FORM 10-K/A | Amended Annual Report.  Auddia Inc (AUUD) +34% Announces Strategic Product Expansion With Cloud Based Artificial Intelligence and Natura","market":"us","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/522334235/image_522334235.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/522334235/image_522334235.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4096200-nktr-imnm-and-maia-are-among-premarket-gainers","is_publish_highlight":false,"gpt_icon":0},{"id":"2431852183","title":"NKGen Biotech Shares Rise 15% After FDA Clears Application for Parkinson's Disease Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2431852183","media":"Dow Jones","top":-1,"share":"https://ttm.financial/m/news/2431852183?lang=en_us&edition=fundamental","pubTime":"2024-04-29 20:53","pubTimestamp":1714395180,"startTime":"0","endTime":"0","summary":"NKGen Biotech shares rose after the company said the Food and Drug Administration cleared its investigational new drug application for SNK01 NK cell therapy to treat Parkinson's disease.Shares were up 15% to $1.85 in premarket trading. The stock closed Friday's session down 19%, and was down 84% for the past 12 months at Friday's close.The biotechnology company said the FDA clearance enables it to initiate a Phase 1/2a clinical trial evaluating the safety, tolerability, and exploratory efficacy of SNK01 in patients with Parkinson's.The trial is designed to enroll up to 30 patients, with 20 receiving SNK01 and 10 receiving a placebo. NKGen expects to begin the trial, with the first patient dosed, in the second half of 2024.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"gpt_icon":0},{"id":"2431854199","title":"PHG, IBRX and MESO are among premarket gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2431854199","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2431854199?lang=en_us&edition=fundamental","pubTime":"2024-04-29 20:36","pubTimestamp":1714394210,"startTime":"0","endTime":"0","summary":"Gainers: Deciphera Pharmaceuticals  +71%. Koninklijke Philips  +41%. ZyVersa Therapeutics  +36%. HWH International  +16%. NewGenIvf Group  +16%. iClick Interactive Asia Group  +14%. Immunity  +13%. Solowin  +13%. NKGen Biotech  +3% Announces FDA Clearance of Investigational New Drug  Application for SNK01 NK Cell Therapy in Parkinson’s Disease  Fulton Financial  +12% surges after Republic First deal and upgrade at Janney.  Tesla  +11% moment in China helps lift Chinese electric vehicle stocks.  Mesoblast  +9%. WISeKey International  +8% Strengthens Its Strategic Partnership with Swiss Armed Forces in the Space Sector for 2024 and Beyond; Plans Include the Launch of an Enhanced WISeSat Satellite in Q3 2024 Using SpaceX.  Dominos Pizza  +6% rallies after comparable sales growth sizzles in Q1  AGBA Group  +6%. MicroCloud Hologram  +6%. VivoPower International  +6% to sell Kenshaw Electrical  ABVC BioPharma  +6%. WiSA Technologies  +5%. Paramount Global  +5% makes 'best and final' offer fo","market":"sg","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/522334235/image_522334235.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/522334235/image_522334235.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4095430-phg-ibrx-and-meso-are-among-premarket-gainers","is_publish_highlight":false,"gpt_icon":0},{"id":"2431855087","title":"BRIEF-Nkgen Biotech Expects To Initiate Phase 1 Clinical Trial For PD In 2H2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2431855087","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2431855087?lang=en_us&edition=fundamental","pubTime":"2024-04-29 20:03","pubTimestamp":1714392218,"startTime":"0","endTime":"0","summary":"April 29  - Nkgen Biotech Inc   :   * NKGEN BIOTECH ANNOUNCES FDA CLEARANCE OF INVESTIGATIONAL NEW DRUG  APPLICATION FOR SNK01 NK CELL THERAPY IN PARKINSON’S DISEASE   * NKGEN BIOTECH INC: EXPECTS TO INITIATE A PHASE 1 CLINICAL TRIAL IN PD IN 2H 2024.Source text for Eikon:    Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2431856674","title":"NKGen Biotech Announces FDA Clearance of Investigational New Drug (IND) Application for SNK01 NK Cell Therapy in Parkinson’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2431856674","media":"GlobeNewswire","top":-1,"share":"https://ttm.financial/m/news/2431856674?lang=en_us&edition=fundamental","pubTime":"2024-04-29 20:00","pubTimestamp":1714392000,"startTime":"0","endTime":"0","summary":"NKGen advances its neurodegenerative disease program with FDA IND clearance for its Phase 1/2a SNK01 Clinical Trial in patients with Parkinson’s disease.The Company expects to initiate a Phase 1 clinical trial in PD in 2H 2024.Dr. Song further commented, “Given the encouraging outcomes regarding the reduction in neuroinflammation observed in our Phase 1 Alzheimer’s trials, we are optimistic about the potential benefits that may emerge in our Parkinson’s trial. Although these two neurodegenerative diseases differ, both share a neuroinflammatory component, which has led to our hypothesis that SNK01 may be beneficial in both indications. While directly inhibiting neuroinflammation, whether as an independent approach or in conjunction with other interventions, may not address the etiology, it can potentially decrease the production of factors that contribute to neurotoxicity, thereby hopefully leading to clinical improvements.”","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/B1ZPiw9UAepRzBSTCPQGgA--~B/aD04NTY7dz0yOTE3O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/ff5a796e664612eddb6f6d9bc19bccdf","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/B1ZPiw9UAepRzBSTCPQGgA--~B/aD04NTY7dz0yOTE3O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/ff5a796e664612eddb6f6d9bc19bccdf"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nkgen-biotech-announces-fda-clearance-120000042.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429453590","title":"ING, PALI and FNCH among pre-market losers","url":"https://stock-news.laohu8.com/highlight/detail?id=2429453590","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2429453590?lang=en_us&edition=fundamental","pubTime":"2024-04-24 20:45","pubTimestamp":1713962723,"startTime":"0","endTime":"0","summary":"Losers: Evotec SE  -31% reports FY results  Finch Therapeutics Group  -14%. NKGen Biotech  -14%. HWH International  -13%. Neo-Concept International Group Holdings Ltd.  -12%. SILO Pharma  -9%. AGBA Group Holding Limited  -9%. Equinox Gold Corp  -8% buys rest of Greenstone gold mine in $995M cash and stock deal.  Enphase Energy  -7% after Q1 earnings release. ING Groep N.V.  -6%. Zhongchao  -6%. Cazoo Group Ltd  -6%. Palisade Bio  -5%.   More on pre-market losers & stocks.  ING: Still Too Cheap Despite Disappointing Results ING Groep NV  Q4 2023 Earnings Call Transcript Palisade Bio stock rallies nearly 100% on colitis drug analysis Palisade Bio stock slides 8% amid colitis drug presentation Financial information for Finch Therapeutics","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4093088-ing-pali-and-fnch-among-pre-market-losers","is_publish_highlight":false,"gpt_icon":0},{"id":"2429194866","title":"HRTX, MESO and POET are among premarket gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2429194866","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2429194866?lang=en_us&edition=fundamental","pubTime":"2024-04-23 20:48","pubTimestamp":1713876530,"startTime":"0","endTime":"0","summary":"Gainers: HWH International  +37%. Smart for Life  +32%. NKGen Biotech  +31%. Hibbett  +19% to acquire Hibbett in $1.1B deal  Immunity  +18% stock jumps as FDA clears bladder cancer therapy  SILO Pharma  +26% Announces Positive Results for Intranasal PTSD Treatment  AGBA Group Holding  +15%. Edible Garden  +17% regains compliance with Nasdaq bid price requirement  Oportun Financial  +15% Announces Preliminary Q1 2024 Financial Information  Zhongchao  +13%. Cango  +9% authorizes new $50 million share buyback program  Gorilla Technology Group  +9%. Danaher  +8% gains as Q1 results exceed expectations  POET Technologies  +7%. Wetouch Technology  +7% Technology grows 2024 revenue by 41%  Spotify Technology  +7% rises as premium subscribers grow in Q1, despite lower than expected monthly users  WiSA Technologies  +6%. Mesoblast  +6%. PENN Entertainment  +6% Names Aaron LaBerge Chief Technology Officer  SES AI Corporation  +6% Announces its May 2024 Event Calendar  Heron Therapeutics  +5%. Ki","market":"fut","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/522334235/image_522334235.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/522334235/image_522334235.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4092436-hrtx-meso-and-poet-are-among-premarket-gainers","is_publish_highlight":false,"gpt_icon":0},{"id":"2429287979","title":"MRIN, WISA and SMFL among mid-day movers","url":"https://stock-news.laohu8.com/highlight/detail?id=2429287979","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2429287979?lang=en_us&edition=fundamental","pubTime":"2024-04-23 00:52","pubTimestamp":1713804734,"startTime":"0","endTime":"0","summary":"Gainers: Matterport  +180%. mF International Ltd  +149%. Edible Garden AG  +84%. AGBA Group Holding Limited  +81%. Moolec Science  +64%. NKGen Biotech  +28%. Tungray Technologies Inc Class A Ordinary Shares  +25%. ProKidney Corp  +24%.  Smart for Life  +24%. Captivision  +23%.  Losers: YY Group Holding Limited Class A Ordinary Shares  -30%. Bio-Path Holdings  -30%. Telomir Pharmaceuticals  -27%. Hepion Pharmaceuticals  -26%. Inhibikase Therapeutics  -26%. Top Wealth Group Holding Limited  -24%. WiSA Technologies  -20%. Iczoom Group  -19%. Marin Software  -19%. Redwoods Acquisition Corp  -19%.   More on Mid-day movers & stocks.  Marin Software Incorporated  Q4 2023 Earnings Call Transcript WiSA signs its fifth WiSA E licensing deal with major consumer electronics company WiSA jumps on announcing fourth HDTV/PTV license with major TV brand Financial information for Marin Software  Financial information for Smart for Life","market":"fut","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1215119911/image_1215119911.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1215119911/image_1215119911.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4092072-mrin-wisa-and-smfl-among-mid-day-movers","is_publish_highlight":false,"gpt_icon":0},{"id":"2429592442","title":"Lexicon Pharmaceuticals, Bio-Path Holdings, Protara Therapeutics among healthcare movers","url":"https://stock-news.laohu8.com/highlight/detail?id=2429592442","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2429592442?lang=en_us&edition=fundamental","pubTime":"2024-04-22 22:01","pubTimestamp":1713794472,"startTime":"0","endTime":"0","summary":"Gainers: Moolec Science SA MLEC +86%. NKGen Biotech  +18%. Protara Therapeutics  +13%. Lexicon Pharmaceuticals  +11%. ProKidney  +7%.  Losers: Hepion Pharmaceuticals HEPA -33%. Inhibikase Therapeutics IKT -18%. Bio-Path Holdings  -18%. Windtree Therapeutics  -19%. Jin Medical International  -14%.   S&P 500 Health Care Sector +0.08% to 1620.1. Health Care Equipment & Services -0.32% to 1909.94. Pharmaceuticals, Biotechnology & Life Science which contributes 58% to index is +0.37% to 1312.04.  More on Health Care Select Sector SPDR  XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Tech advances are catalyzing the Health Care sector with improved investor sentiment - SSGA Short interest in S&P 500 health stocks rises, Moderna among most shorted companies in March Seeking Alpha’s Quant Rating on Health Care Select Sector SPDR","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4091930-lexicon-pharmaceuticals-bio-path-holdings-protara-therapeutics-among-healthcare-movers","is_publish_highlight":false,"gpt_icon":0},{"id":"2429928601","title":"OGI, FMS and POET are among premarket gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2429928601","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2429928601?lang=en_us&edition=fundamental","pubTime":"2024-04-22 20:21","pubTimestamp":1713788508,"startTime":"0","endTime":"0","summary":"Gainers: Moolec Science  +113% achieves USDA approval for plant-grown animal proteins, shares jump.  NKGen Biotech  +37%. AGBA Group Holding  +22%. POET Technologies  +14%. Tungray Technologies  +14%. Syra Health  +10% wins Training Contract from Sedgwick County Health Department in Kansas to Combat Substance Use Disorder.  Gryphon Digital Mining  +9% Announces Stock Repurchase Program; Machine Upgrade Program Completed Ahead of Schedule.  Fresenius Medical Care  +7%. Lytus Technologies  +6%. OrganiGram  +6%. Zapata Computing  +6%. Marti Technologies  +6%. Riot Platforms  +5% INFA, crypto-related stocks and more.  ARB IOT Group  +5%.   More on premarket gainers & stock  Organigram Is My Favorite Cannabis Stock Again Organigram: Operating In A Structurally Challenged Industry Broyhill - Fresenius Medical Care: Correctly Focused On Increasing Margins And Returns Canadian cannabis stocks rally as industry exec. elected to lead lobby group Organigram's SHRED brand surpasses $200M in yearly","market":"hk","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/522334235/image_522334235.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/522334235/image_522334235.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4091859-ogi-fms-and-poet-are-among-premarket-gainers","is_publish_highlight":false,"gpt_icon":0},{"id":"2426859266","title":"BRIEF-NKGen Biotech Secures Additional Financing of $5 Mln To Continue Advancing Its Clinical Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2426859266","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2426859266?lang=en_us&edition=fundamental","pubTime":"2024-04-11 22:33","pubTimestamp":1712846032,"startTime":"0","endTime":"0","summary":"April 11  - Nkgen Biotech Inc   :   * NKGEN BIOTECH SECURES ADDITIONAL FINANCING OF $5 MILLION TO CONTINUE ADVANCING ITS CLINICAL PROGRAMS   * NKGEN BIOTECH INC: COMPANY'S NEURODEGENERATIVE CLINICAL PROGRAM REMAINS ON TRACKSource text for Eikon:    Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2426682254","title":"NKGen Biotech Secures $5M in Strategic Financing Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2426682254","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2426682254?lang=en_us&edition=fundamental","pubTime":"2024-04-11 20:22","pubTimestamp":1712838157,"startTime":"0","endTime":"0","summary":"NKGen Biotech (NKGN) has provided an update. NKGen Biotech, Inc. has secured a flexible financing deal through an equity and business loan agreemen...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nkgen-biotech-secures-5m-in-strategic-financing-deal?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nkgen-biotech-secures-5m-in-strategic-financing-deal?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2426256378","title":"Press Release: NKGen Biotech Secures Additional Financing of $5 Million to Continue Advancing Its Clinical Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2426256378","media":"Dow Jones","top":-1,"share":"https://ttm.financial/m/news/2426256378?lang=en_us&edition=fundamental","pubTime":"2024-04-11 20:05","pubTimestamp":1712837100,"startTime":"0","endTime":"0","summary":"The Company's neurodegenerative clinical program remains on track, with continued advancement of the Alzheimer's Phase 2 trial and anticipation of Parkinson's Phase 1/2a trial initiation.Additional financing also to support the Company's oncology clinical program, with interim safety data readout in Q2 for its allogeneic product candidate.Dr. Song continued, \"We are intently focused on our upcoming Phase 2 Alzheimer's clinical trial and recently submitted an IND for Parkinson's disease while streamlining our resources for maximum efficiency. Accordingly, we have successfully reduced our monthly burn rate for operations and clinical trials by almost 50%. In addition, we have several catalysts expected this year including data readouts  for the Phase 1 portion of our moderate Alzheimer's trial and the initiation of Phase 2.\"","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"gpt_icon":0},{"id":"2425916219","title":"Galectin Therapeutics, Titan Pharmaceuticals, Outset Medical among healthcare movers","url":"https://stock-news.laohu8.com/highlight/detail?id=2425916219","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2425916219?lang=en_us&edition=fundamental","pubTime":"2024-04-08 22:00","pubTimestamp":1712584833,"startTime":"0","endTime":"0","summary":"Gainers: Longeveron  +66%. Titan Pharmaceuticals  +23%. MSP Recovery  +19%. Outset Medical  +16%. Palatin Technologies  +11%.  Losers: Zhongchao  -11%. Adial Pharmaceuticals  -9%. Galectin Therapeutics  -8%. NKGen Biotech  -7%. Allurion Technologies  -7%.   S&P 500 Health Care Sector -0.3% to 1665.92. Health Care Equipment & Services -0.39% to 1933.01. Pharmaceuticals, Biotechnology & Life Science which contributes 58% to index is -0.27% to 1364.51.  More on Health Care Select Sector SPDR  XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run Top buy-rated stocks and sell-rated stocks within Health Care - Citi Eli Lilly tops S&P 500 healthcare sector in Q1 as weight loss frenzy continues","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4087926-galectin-therapeutics-titan-pharmaceuticals-outset-medical-among-healthcare-movers","is_publish_highlight":false,"gpt_icon":0},{"id":"2422572908","title":"BRIEF-Nkgen Biotech Presents Additional Phase 1 Clinical Trial Data In Alzheimer’S Disease At The Tau2024 Global Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2422572908","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2422572908?lang=en_us&edition=fundamental","pubTime":"2024-03-26 06:00","pubTimestamp":1711404019,"startTime":"0","endTime":"0","summary":"March 25 (Reuters) - Nkgen Biotech Inc   :   * NKGEN BIOTECH PRESENTS ADDITIONAL PHASE 1 CLINICAL TRIAL DATA IN ALZHEIMER’S DISEASE AT THE TAU2024 GLOBAL CONFERENCESource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2422457368","title":"NKGen Biotech Presents Additional Phase 1 Clinical Trial Data in Alzheimer’s Disease at the Tau2024 Global Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2422457368","media":"GlobeNewswire","top":-1,"share":"https://ttm.financial/m/news/2422457368?lang=en_us&edition=fundamental","pubTime":"2024-03-26 04:05","pubTimestamp":1711397100,"startTime":"0","endTime":"0","summary":"SNK01 autologous NK cell therapy demonstrated a positive effect on cerebral spinal fluid  and plasma Tau proteins in Alzheimer’s patients.The additional Phase 1 SNK01 trial data suggest clinical activity regarding cognitive function in patients with advanced Alzheimer’s disease in addition to previously disclosed positive effects on amyloid protein and neuroinflammation biomarkers.The presentation contained data from an abstract entitled, “Beneficial Effect on CSF and Plasma Tau Proteins and Cognitive Function in Alzheimer’s Disease Subjects Treated with Expanded Non-Genetically Modified Autologous Natural Killer Cells .” In this Phase 1 study, SNK01 was administered intravenously  every three weeks for a total of four treatments using a 3+3 dose escalation design  in patients with either mild, moderate, or severe AD . Cognitive assessments and CSF/plasma pTau217 and pTau181 analyses were performed at baseline and at 1 and 12 weeks after the final dose. The primary endpoint was safety ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/B1ZPiw9UAepRzBSTCPQGgA--~B/aD04NTY7dz0yOTE3O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/ff5a796e664612eddb6f6d9bc19bccdf","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/B1ZPiw9UAepRzBSTCPQGgA--~B/aD04NTY7dz0yOTE3O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/ff5a796e664612eddb6f6d9bc19bccdf"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nkgen-biotech-presents-additional-phase-200500597.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2422516441","title":"CGC, KNDI and ESPR are among pre market gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2422516441","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2422516441?lang=en_us&edition=fundamental","pubTime":"2024-03-25 19:55","pubTimestamp":1711367740,"startTime":"0","endTime":"0","summary":"Gainers: MicroAlgo  +51%. Flora Growth  +30%. Esperion Therapeutics  +21%. Moleculin Biotech  +19% Announces Positive Interim Data in Annamycin MB-106 Phase 1B/2 AML Trial.  Nkarta  +17% announces pricing of stock offering to raise $240.1M.  Forge Global Holdings  +16%.  Canopy Growth Corporation  +11%. Axsome Therapeutics  +9% Announces Results of CRESCENDO Narcolepsy Patient Survey Demonstrating Unmet Needs in Treated Narcolepsy Type 1 Patients.  Solowin Holdings  +7%. Digital World Acquisition  +6%. Aemetis  +6%. Inspira Technologies Oxy  +6%. NKGen Biotech  +6%. Cronos Group  +5% Launches Lord Jones Chocolate Fusions  WM Technology  +5%. Kandi Technologies Group  +5%.   More on premarket gainers & stock  Canopy Growth Is Climbing, But It Won't Last Kandi Technologies Group, Inc.  Q4 2023 Earnings Call Transcript A Relief Earnings Report Ahead Of An Inflection Point For Esperion Therapeutics Cannabis stocks rally as Schumer circulates petition for SAFER Banking Act Cannabis stocks r","market":"sg","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/522334235/image_522334235.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/522334235/image_522334235.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4083253-cgc-kndi-and-espr-are-among-pre-market-gainers","is_publish_highlight":false,"gpt_icon":0},{"id":"2421703038","title":"BRIEF-Nkgen Biotech's Sangwoo Park Notified Board He Will Step Down As Chairperson","url":"https://stock-news.laohu8.com/highlight/detail?id=2421703038","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2421703038?lang=en_us&edition=fundamental","pubTime":"2024-03-21 04:05","pubTimestamp":1710965156,"startTime":"0","endTime":"0","summary":"March 21  - Nkgen Biotech Inc   :   * NKGEN BIOTECH INC -  ON MARCH 14 SANGWOO PARK NOTIFIED BOARD OF HIS INTENTION TO STEP DOWN AS CHAIRPERSON   * NKGEN BIOTECH INC -  BOARD HAS APPOINTED PAUL Y. SONG, COMPANY'S CHIEF EXECUTIVE OFFICER, AS CHAIRPERSONSource text for Eikon:    Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2420700222","title":"OTRK, STRC and APM among mid-day movers","url":"https://stock-news.laohu8.com/highlight/detail?id=2420700222","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2420700222?lang=en_us&edition=fundamental","pubTime":"2024-03-20 00:48","pubTimestamp":1710866906,"startTime":"0","endTime":"0","summary":"Gainers: Fusion Pharmaceuticals  +98%. Ontrak  +96%. SCWorx Corp  +65%. NKGen Biotech  +45%. Li-Cycle Holdings Corp  +42%. Sarcos Technology and Robotics Corporation  +31%. Enliven Therapeutics  +28%. Vincerx Pharma  +28%. Spire Global  +27%.  Aptorum Group Ltd  +26%.  Losers: NuScale Power Corporation  -34%. Comtech Telecommunications Corp.  -26%. Peraso  -23%. Eyenovia  -22%. Unusual Machines  -21%. Zepp Health Corporation ADR  -21%. ShiftPixy  -20%. Lantern Pharma  -20%. Mercurity Fintech Holding  -17%. Spectral AI  -17%.   More on Mid-day movers & stocks.  Ontrak Health announces continuing expansion with Sentara Health Sarcos Technology and Robotics says co-founder Ben Wolff to become CEO Financial information for Aptorum Group Seeking Alpha’s Quant Rating on Ontrak Historical earnings data for Ontrak","market":"hk","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1215119911/image_1215119911.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1215119911/image_1215119911.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4081211-otrk-strc-and-apm-among-mid-day-movers","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.nkgenbiotech.com","stockEarnings":[{"period":"1week","weight":-0.1189},{"period":"1month","weight":0},{"period":"3month","weight":-0.2222},{"period":"6month","weight":-0.5685},{"period":"1year","weight":-0.8767},{"period":"ytd","weight":-0.5418}],"compareEarnings":[{"period":"1week","weight":0.0187},{"period":"1month","weight":0.0131},{"period":"3month","weight":0.0392},{"period":"6month","weight":0.1821},{"period":"1year","weight":0.2638},{"period":"ytd","weight":0.0958}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"NKGen Biotech, Inc. operates as a clinical-stage biotechnology company that focuses on the development and commercialization of autologous, allogeneic, and CAR-NK natural killer cell therapies. It develops SNK01, an autologous NK cell therapy; and SNK02, an allogeneic NK cell therapy, which are in Phase 1 clinical trials. The company was founded in 2017 and is based in Santa Ana, California.","exchange":"NYSE","name":"NKGEN BIOTECH INC","nameEN":"NKGEN BIOTECH INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"NKGEN BIOTECH INC(NKGN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest NKGEN BIOTECH INC(NKGN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"NKGEN BIOTECH INC,NKGN,NKGEN BIOTECH INC股票,NKGEN BIOTECH INC股票老虎,NKGEN BIOTECH INC股票老虎国际,NKGEN BIOTECH INC行情,NKGEN BIOTECH INC股票行情,NKGEN BIOTECH INC股价,NKGEN BIOTECH INC股市,NKGEN BIOTECH INC股票价格,NKGEN BIOTECH INC股票交易,NKGEN BIOTECH INC股票购买,NKGEN BIOTECH INC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"NKGEN BIOTECH INC(NKGN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest NKGEN BIOTECH INC(NKGN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}